Vivos Inc. (RDGL)
OTCMKTS · Delayed Price · Currency is USD
0.0700
+0.0011 (1.60%)
Jan 20, 2026, 4:00 PM EST
Vivos Market Cap
Vivos has a market cap or net worth of $31.38 million as of January 20, 2026. Its market cap has decreased by -37.81% in one year.
Market Cap
31.38M
Enterprise Value
38.53M
Revenue
48.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since September 1, 1998, Vivos's market cap has increased from 12.08M to 31.38M, an increase of 159.73%. That is a compound annual growth rate of 3.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 31.38M | 0.07% |
| Dec 31, 2025 | 31.36M | -37.86% |
| Dec 31, 2024 | 50.47M | 81.66% |
| Dec 29, 2023 | 27.78M | 73.14% |
| Dec 30, 2022 | 16.05M | -44.73% |
| Dec 31, 2021 | 29.03M | -5.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |